Prolonged remission of severe Crohn's disease after fever and leukopenia caused by 6-mercaptopurine

Digestive Diseases and Sciences

Volumn 49, Issue 2, 2004, Pages 336-338

  Lobel, Efrat Z ^a   Korelitz, Burton I ^a,b   Vakher, Katherine ^a   Panagopoulos, Georgia ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LENOX HILL HOSPITAL   (United States)

Author keywords

6MP; Crohn's disease; Leukopenia; Remission

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLON RESECTION; COLOSTOMY; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; LEUKOPENIA; MALE; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADULT; CROHN DISEASE; FEMALE; FEVER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOPENIA; MALE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 1642296087     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000017461.51974.3b     Document Type: Article

References (13)

1. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS: Treatment of Crohn's disease with 6-mercaptopurine: A long term, randomized, double-blind study. N Engl J Med 302:981-987, 1980
2. Colonna T, Korelitz BI: The role of leukopenia in the 6 mercaptopurine induced remission of refractory Crohn's disease. Am J Gastroenterol 89:362-366, 1994
3. Candy S, Wright J, Gerber M: A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 37:674-678, 1995
4. Fraser AG, Orchard TR, Jewell DP: The efficacy of azathioprine for the treatment of inflammatory bowel disease; A 30 year review. Gut 50:485-489, 2002
5. Coulthard SA, Hall AG: Recent advances in the pharmacogenetics of thiopurine methyltransferase. Pharmacogenomics J 1:254-261, 2001
6. Cuffari C, Theoret Y, Latour S, Seidman G: 6-Mercaptopurine metabolism in Crohn's disease: Correlation with efficacy and toxicity. Gut 39:401-406, 1996
7. Dubinsky MC, Lamotta S, Yang HY, et al.: Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 118:705-713, 2000
8. Sandborn WJ: Rational dosing of azathioprine and 6-mercaptopurine. Gut 48:591-592, 2001
9. Lennard L: TPMT in the treatment of Crohn's disease with azathioprine. Gut 51:143-146, 2002
10. Van Lindert AC, Symons EA, Damen BF, Heintz AP: Wound healing after radical vulvectomy and inguino femoral lymphadenectomy: Experience with granulocyte colon stimulating factor. Eur J Obstet Gynecol Reprod Biol 62:217-219, 1995
11. Vaughn, D, Drumn B: Treatment of fistulas with granulocyte colony stimulating factor in patient with Crohn's disease. N Engl J Med 34:239-240, 1999
12. Gough A, Clapperton M, Tolando N, Foster AV: Randomized placebo controlled trial of granulocyte colony stimulating factor in diabetic foot infection. Lancet 350:855-859, 1997
13. Pizzo P: Fever in the immunocompromised patient. N Engl J Med 341:893-900, 1999